Precision Health Clinical Trials
Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers
Conditions: Pancreatic Cancer; Metastatic Breast Cancer; Metastatic Lung Cancer; Metastatic Colon Cancer; Metastatic Melanoma; Metastatic Prostate Cancer
Intervention: Diagnostic Test: NantHealth GPS Cancer Test
Sponsors: Cota Inc.; Blue Cross Blue Shield; NantHealth Inc.
Recruiting
Intervention: Diagnostic Test: NantHealth GPS Cancer Test
Sponsors: Cota Inc.; Blue Cross Blue Shield; NantHealth Inc.
Recruiting
For more information, visit the Study URL.
Detection of Tumor DNA in Blood Samples From Patients With Early Stage Cancer and "Healthy Controls"
Condition: Neoplasms, Non-hematologic - Stage I-III
Intervention:
Sponsor: Lexent Bio, Inc.
Recruiting
Intervention:
Sponsor: Lexent Bio, Inc.
Recruiting
For more information, visit the Study URL.
McLean and Genomind Prospective Study
Conditions: Major Depressive Disorder; PTSD
Interventions: Genetic: Phlebotomy - Folate; Genetic: Cheek Swab; Other: Self-report surveys
Sponsors: Mclean Hospital; Genomind, LLC
Recruiting
Interventions: Genetic: Phlebotomy - Folate; Genetic: Cheek Swab; Other: Self-report surveys
Sponsors: Mclean Hospital; Genomind, LLC
Recruiting
For more information, visit the Study URL.
P53 Mutational Status and cf HPV DNA for the Management of HPV-associated OPSCC
Conditions: Carcinoma, Squamous Cell; Head and Neck Neoplasms; Oropharyngeal Neoplasms
Interventions: Radiation: Intensity Modulated Radiotherapy (IMRT) - deintensified; Radiation: Intensity Modulated Radiotherapy (IMRT) - standard; Drug: Cisplatin (or alternative) - deintensified; Drug: Cisplatin (or alternative) - standard; Procedure: Assessment for surgical evaluation
Sponsor: UNC Lineberger Comprehensive Cancer Center
Recruiting
Interventions: Radiation: Intensity Modulated Radiotherapy (IMRT) - deintensified; Radiation: Intensity Modulated Radiotherapy (IMRT) - standard; Drug: Cisplatin (or alternative) - deintensified; Drug: Cisplatin (or alternative) - standard; Procedure: Assessment for surgical evaluation
Sponsor: UNC Lineberger Comprehensive Cancer Center
Recruiting
For more information, visit the Study URL.
Genetics of Ehlers-Danlos Syndrome
Conditions: Genetics Syndrome; Ehlers-Danlos Syndrome
Intervention: Diagnostic Test: Genotyping
Sponsor: Boston University
Recruiting
Intervention: Diagnostic Test: Genotyping
Sponsor: Boston University
Recruiting
For more information, visit the Study URL.
Composition and Collection Feasibility of Gut Microbiota in Children With and Without Obesity
Condition: Childhood Obesity
Intervention:
Sponsor: University of Illinois College of Medicine at Peoria
Recruiting
Intervention:
Sponsor: University of Illinois College of Medicine at Peoria
Recruiting
For more information, visit the Study URL.
Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study III
Conditions: Lymphoma, Non-Hodgkin; Lymphoma, Hodgkin
Intervention: Drug: Chemotherapy
Sponsors: Samsung Medical Center; Samsung Genomic Institute
Recruiting
Intervention: Drug: Chemotherapy
Sponsors: Samsung Medical Center; Samsung Genomic Institute
Recruiting
For more information, visit the Study URL.
Genetics of Differences of Sex Development and Hypospadias
Conditions: Disorders of Sex Development; Hypospadias
Intervention: Genetic: Return of Genetic Results
Sponsor: Boston Children's Hospital
Recruiting
Intervention: Genetic: Return of Genetic Results
Sponsor: Boston Children's Hospital
Recruiting
For more information, visit the Study URL.
Chilean Gastric Cancer Task Force (FORCE 1)
Condition: Biomarkers
Intervention:
Sponsors: Pontificia Universidad Catolica de Chile; Center of Excellence of Precision Medicine (CEMP); Advanced Center for Chronic Diseases (ACCDiS); Millennium Institute on Immunology and Immunotherapy; Center UC for Investigation in Oncology (CITO); Centre of Clinical Research, Health Technology Assessment Unit; National Scientific and Technical Research Council (CONICET), Argentina; Grupo Oncologico Cooperativo del Sur (GOCS), Argentina; Hospital Universitario central de Asurias, Oviedo, España; Hospital Morales Meseger, Murcia, España; Centro de Cancer. Pontificia Universidad Católica de Chile; Hematology and Oncology Department
Recruiting
Intervention:
Sponsors: Pontificia Universidad Catolica de Chile; Center of Excellence of Precision Medicine (CEMP); Advanced Center for Chronic Diseases (ACCDiS); Millennium Institute on Immunology and Immunotherapy; Center UC for Investigation in Oncology (CITO); Centre of Clinical Research, Health Technology Assessment Unit; National Scientific and Technical Research Council (CONICET), Argentina; Grupo Oncologico Cooperativo del Sur (GOCS), Argentina; Hospital Universitario central de Asurias, Oviedo, España; Hospital Morales Meseger, Murcia, España; Centro de Cancer. Pontificia Universidad Católica de Chile; Hematology and Oncology Department
Recruiting
For more information, visit the Study URL.
Genetic Variants in Egyptian Patients Receiving HCQ(Hydroxychloroquine)
Condition: Autoimmune Diseases
Intervention: Drug: Hydroxychloroquine Oral Tablet
Sponsor: Assiut University
Not yet recruiting
Intervention: Drug: Hydroxychloroquine Oral Tablet
Sponsor: Assiut University
Not yet recruiting
For more information, visit the Study URL.